Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $13.20 up 1.85% from its previous closing price of $12.96. In other words, the price has increased by $1.85 from its previous closing price. On the day, 0.88 million shares were traded. SPRY stock price reached its highest trading level at $13.37 during the session, while it also had its lowest trading level at $12.561.
Ratios:
For a deeper understanding of ARS Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 32.78 and its Current Ratio is at 32.78. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 21 ’24 when Thompson Peter A. sold 407,700 shares for $13.56 per share. The transaction valued at 5,526,601 led to the insider holds 544,677 shares of the business.
Thompson Peter A. sold 391,482 shares of SPRY for $5,065,777 on Aug 22 ’24. The Director now owns 153,195 shares after completing the transaction at $12.94 per share. On Aug 23 ’24, another insider, Thompson Peter A., who serves as the Director of the company, sold 69,500 shares for $13.03 each. As a result, the insider received 905,585 and left with 83,695 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1279629056 and an Enterprise Value of 1061045248. For the stock, the TTM Price-to-Sale (P/S) ratio is 2559.22 while its Price-to-Book (P/B) ratio in mrq is 5.94. Its current Enterprise Value per Revenue stands at 2122.09 whereas that against EBITDA is -18.722.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $16.50, while it has fallen to a 52-week low of $2.55. The 50-Day Moving Average of the stock is 26.46%, while the 200-Day Moving Average is calculated to be 62.47%.
Shares Statistics:
For the past three months, SPRY has traded an average of 948.43K shares per day and 2079680 over the past ten days. A total of 96.41M shares are outstanding, with a floating share count of 47.68M. Insiders hold about 50.82% of the company’s shares, while institutions hold 37.73% stake in the company. Shares short for SPRY as of 1722384000 were 9925990 with a Short Ratio of 10.47, compared to 1719532800 on 6881590. Therefore, it implies a Short% of Shares Outstanding of 9925990 and a Short% of Float of 19.29.
